Luminescent Heterobimetallic PtII-AuI Complexes Bearing N-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents

This study aims to probe into new series of heterobimetallic PtII-AuI complexes with a general formula of [Pt(p-MeC6H4)(dfppy)(μ-dppm)Au(NHC)]OTf, NHC = IPr, 2; IMes, 3; dfppy = 2-(2,4-difluorophenyl)pyridinate; dppm = 1,1-bis(diphenylphosphino)methane, which are the resultant of the reaction between [Pt(p-MeC6H4)(dfppy)(κ1-dppm)], 1, with [AuCl(NHC)], NHC = IPr, B; IMes, C, in the presence of [Ag(OTf)]. In the heterobimetallic complexes, the dppm ligand is settled between both metals as an unsymmetrical bridging ligand. Several techniques are employed to characterize the resulting compounds. Moreover, the photophysical properties of the complexes are investigated by means of UV-vis and photoluminescence spectroscopy. Furthermore, the experimental study is enriched by ab initio calculations (density functional theory (DFT) and time-dependent DFT (TD-DFT)) to assess the role of Pt and Au moieties in the observed optical properties. It is revealed that 1-3 is luminescent in the solid state and solution at different temperatures. In addition, the achieved results indicate the emissive properties of 1-3 are originated from a mixed 3IL/3MLCT excited state with major contribution of intraligand charge transfer (dfppy). A comparative study is conducted into the cytotoxic activities of starting materials and 1-3 against different human cancer cell lines such as the pancreas (MIA-PaCa2), breast (MDA-MB-231), cervix (HeLa), and noncancerous breast epithelial cell line (MCF-10A). The achieved results suggest the heterobimetallic PtII-AuI species as optimal compounds that signify the existence of cooperative and synergistic effects in their structures. The complex 3 is considered as the most cytotoxic compound with the maximum selectivity index in our screened complex series. Moreover, it is disclosed that 3 effectively causes cell death by inducing apoptosis in MIA-PaCa2 cells. Furthermore, the finding results by fluorescent cell microscopy manifest cytoplasmic staining of 3 rather than nucleus.

Phosphorescent Pt(II) Complexes Bearing Cyclometalated Diflurophenylpyridinate and Diphosphine Building Blocks

Two distinct categories of cycloplatinated(II) complexes [Pt(dfppy)(P^P)]Cl, 2, and [Pt2Cl2(dfppy)2(μ-P^P)], 3, where dfppy = 2-(2,4-difluorophenyl)pyridinate, P^P = bis(diphenylphosphino)methane (dppm), 1,2-bis(diphenylphosphino)ethane (dppe) and 1,2-bis(diphenylphosphino)benzene (dppbz), were synthesized and characterized. These compounds...

Phosphorescent Cyclometalated Ir(III) Complexes Comprising Chelating Thiolate Ligands as pH-Activatable Sensors

A series of cyclometalated Ir(III) complexes possessing the general formula of [Ir(pqe)2(S^N)], pqe = 2-phenyl-quinoline-4-carboxylic acid methyl ester, S^N = pyridine-2-thiolate (Spy, B1); pyrimidine-2-thiolate (SpyN, B2); 5-(trifluoromethyl)-pyridine-2-thiolate (SpyCF3, B3); 2-thiazoline-2-thiolate...

Binuclear platinum(II) complexes bearing various bridging 1,1'-diphosphinoferrocene ligands as potential anticancer agents: Synthesis and biological evaluations

Novel binuclear platinum(II) complexes driven by C^N cyclometalated ligands with the general formula [Pt2(C^N)2Cl2(µ-L)], where C^N = 2-phenylpyridine (ppyH) or 2-(2,4-difluorophenyl) pyridine (dfppyH) and L = 1,1'-bis(diphenylphosphino)ferrocene (dppf), 1,1'- bis(diisopropylphosphino)ferrocene...